Process for producing extracted lipid comprising docosahexaenoic acid

US11306271B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11306271-B2
Application numberUS-202016868324-A
CountryUS
Kind codeB2
Filing dateMay 6, 2020
Priority dateJun 15, 2012
Publication dateApr 19, 2022
Grant dateApr 19, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for producing ethyl esters of polyunsaturated fatty acids, comprising transesterifying triacylglycerols in extracted plant lipid.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for producing extracted lipid, comprising the steps of: a) obtaining Brassica napus or Camelina sativa seed comprising extractable lipid having a total fatty acid content, the lipid comprising fatty acids esterified as triacylglycerols (TAG), the fatty acids comprising oleic acid, palmitic acid, linoleic acid (LA), γ-linolenic acid (GLA), α-linolenic acid (ALA), stearidonic acid (SDA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and eicosatetraenoic acid (ETA), wherein at least 70% by weight of the DHA which is esterified in the form of TAG is esterified at the sn-1 or sn-3 position of TAG, and b) extracting lipid from the seed. 2. The process of claim 1 , wherein EPA, DPA and DHA, and optionally arachidonic acid (ARA), are each present at a level in the total fatty acid content, each level being expressed as a percentage of the total fatty acid content, whereby the sum total of the levels of ARA, EPA, DPA and DHA in the extractable lipid is between 7% and 25% by weight of the total fatty acid content. 3. The process of claim 1 , wherein GLA is present in the extracted lipid at a level of less than 2% by weight of the total fatty acid content. 4. The process of claim 3 , wherein at least 80% by weight of the DHA esterified in the form of TAG in the extracted lipid is at the sn-1 or sn-3 position of TAG. 5. The process of claim 1 , wherein SDA, ETA, EPA, DPA and DHA are each present at a level in the total fatty acid content, each level being expressed as a percentage by weight of the total fatty acid content, whereby the sum of the percentages for ETA, EPA, DPA and DHA divided by the sum of the percentages for SDA, ETA, EPA, DPA and DHA, expressed as a percentage, is at least 75%. 6. The process of claim 5 , wherein at least 80% by weight of the DHA esterified in the form of TAG in the extracted lipid is at the sn-1 or sn-3 position of TAG. 7. The process of claim 1 , wherein ETA, EPA, DPA and DHA are each present at a level in the total fatty acid content, each level being expressed as a percentage by weight of the total fatty acid content, whereby the sum of the percentages for EPA, DPA and DHA divided by the sum of the percentages for ETA, EPA, DPA and DHA, expressed as a percentage, is between 75% and 98%. 8. The process of claim 7 , wherein at least 80% by weight of the DHA esterified in the form of TAG in the extracted lipid is at the sn-1 or sn-3 position of TAG. 9. The process of claim 1 , wherein DHA is present in the extracted lipid at a level of between 2.7% and 3.3% by weight of the total fatty acid content. 10. The process of claim 1 , wherein DHA is present in the extracted lipid at a level of between 7% and 20% by weight of the total fatty acid content. 11. The process of claim 1 , further comprising a step of purifying the extracted lipid. 12. The process of claim 2 , further comprising a step of purifying the extracted lipid. 13. The process of claim 3 , further comprising a step of purifying the extracted lipid. 14. The process of claim 4 , further comprising a step of purifying the extracted lipid. 15. The process of claim 1 , further comprising a step of transesterifying the extracted lipid to thereby produce fatty acid esters. 16. The process of claim 15 , further comprising a step of fractionating the fatty acid esters. 17. The process of claim 1 , wherein the Brassica napus or Camelina sativa seeds of step a) are obtained from Brassica napus or Camelina sativa plants grown in a field as a population of at least 1,000 plants. 18. The process of claim 17 , wherein the process comprises, prior to step a), a step of cultivating the at least 1000 Brassica napus or Camelina sativa plants in the field, and step a) comprises harvesting Brassica napus or Camelina sativa seeds from the at least 1000 Brassica napus or Camelina sativa plants.

Assignees

Inventors

Classifications

  • Brassicaceae, e.g. canola, broccoli or rucola · CPC title

  • involving modified lipid metabolism, e.g. seed oil composition · CPC title

  • Seeds · CPC title

  • by esterification of fatty acids with alcohols (C11C3/02 takes precedence) · CPC title

  • for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11306271B2 cover?
The present invention relates to a process for producing ethyl esters of polyunsaturated fatty acids, comprising transesterifying triacylglycerols in extracted plant lipid.
Who is the assignee on this patent?
Commw Scient Ind Res Org, Grains Res & Dev Corp, Nuseed Nutritional Australia Pty Ltd
What technology area does this patent fall under?
Primary CPC classification C11B1/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).